Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
4.13M
-
Shares change
-
+440K
-
Total reported value, excl. options
-
$96M
-
Value change
-
+$10.6M
-
Number of buys
-
40
-
Number of sells
-
-24
-
Price
-
$23.21
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2020
73 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2020.
IRADIMED CORP - Common Stock (IRMD) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.13M shares
of 12.7M outstanding shares and own 32.47% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (686K shares), BlackRock Inc. (424K shares), Nine Ten Capital Management LLC (416K shares), Russell Investments Group, Ltd. (334K shares), Ranger Investment Management, L.P. (262K shares), RK Capital Management, LLC (244K shares), Soleus Capital Management, L.P. (212K shares), Mondrian Investment Partners LTD (164K shares), RICE HALL JAMES & ASSOCIATES, LLC (149K shares), and NORTHERN TRUST CORP (108K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.